CSCs were initially identified in acute myeloid leukemia (AML) as a CD34+ CD38- subpopulation capable of initiating leukemia after engraftment in immunodeficient mice (Lapidot et al., 1994). Here, CD34 is linked to acute myeloid leukemia.